Dr Magdalena Harris is a Lecturer and Research Fellow at the Centre for Research on Drugs and Health Behaviour, London School of Hygiene and Tropical Medicine. Her background is in Sociology and she has been involved in qualitative HCV-based research for the past ten years, publishing in variety of formats including international peer-reviewed journals and targeted community magazines.

She currently holds a 4 year NIHR postdoctoral fellowship for the project: ‘The hepatitis C treatment journey: A prospective qualitative longitudinal study addressing patient, provider and system perspectives’ and over the past three years has worked as lead researcher on the qualitative investigations: ‘Staying Safe: A sociology of how people who inject drugs avoid hepatitis C in the long term’ and ‘HCVtx: barriers and facilitators to hepatitis C treatment for people who inject drugs.”

Prior to joining LSHTM in 2009, Magdalena was based at the University of New South Wales, Australia where she completed her PhD (‘Negotiating the pull of the normal: Embodied narratives of living with hepatitis C in New Zealand and Australia’) and worked on qualitative studies exploring hepatitis C seroconversion, hepatitis C avoidance/ prevention and Aboriginal Cancer Care.

Magdalena has also had experience of living with, and successfully undergoing treatment for HCV. She is a UK Hepatitis C Trust board member, on the editorial board member for the International Journal of Drug Policy and has provided invited ‘subject expert’ guidance for institutions such as NICE and EMCDDA.